Media coverage
United Neuroscience To Move Forward Alzheimer’s Vaccine After Promising Phase IIa
emily.hayes@informa.com
Executive Summary
It's early days yet and Alzheimer's is a field littered with failures, but the latest results for the vaccine UB-311 support advancing development.
(continue reading: https://scrip.pharmaintelligence.informa.com/SC124500/United-Neuroscience-To-Move-Forward-Alzheimers-Vaccine-After-Promising-Phase-IIa?vid=Pharma)